Sunday, December 21, 2025

Latest

Dollarama: Canaccord Expects Same-Store Sales Growth In Q3

Dollarama (TSX: DOL) is expected to report its third quarter financial results of 2023 this morning. The consensus estimate suggests that revenues will grow $15 million consecutively to $1.23 billion, with this estimate growing slightly over the last twelve months. Analysts expect this revenue growth to continue into gross margins, as they expect gross profits to come in at $543 million, or a 44.1% margin, a 0.5% margin improvement sequentially.

Operating profit is forecasted to come in at $315 million, up sequentially, representing an operating margin of 25.6%. Net income is expected to be $202 million, or earnings per share of $0.70. Once again, these estimates have slowly increased over the last twelve months.

There are 14 analysts covering Dollarama with an average 12-month price target of C$87. Out of the 14 analysts, one has a strong buy rating, eight analysts have buy ratings and the last five analysts have hold ratings on the stock. The street-high price target currently sits at C$95 and represents a 14% upside to the current price.

In Canaccord Genuity Capital Markets’ note on their expectations heading into the print, they reiterate both their hold rating and C$80 12-month price target, saying that they are looking for solid top-line trends to continue, which will help margins.

They expect the company to piggyback off the strong second quarter, where the company reported comparable sales growth of 13.2% year over year, which included a 20% increase in the number of transactions. Off the back of that, Dollarama increased its comparable same-store sales growth to 6.5%-7.5% from 4.0%-5.0%.

Canaccord expects the headwinds that management talked to during the first half of the year, including ongoing inflation, which has driven higher consumables sales, and a lack of health order-related operating restrictions. With Halloween sales being included in this quarter’s print, Canaccord is expecting some store sales to be up 5% year over year.

Additionally, they expect revenues to be $1.23 billion, in line with the consensus estimate. They expect EBITDA to be $382 million and earnings per share of $0.69. Canaccord also anticipates gross margins to be 44.2%, “given persistent consumer inflationary trends.” They expect people to continue to trade down to less expensive items, usually with a lower margin profile.

Lastly, Canaccord talks about SG&A costs, which they believe will stay relatively unchanged as a percent of revenue on a yearly basis. They expect increased wage expenses to offset any increase in operating leverage for the quarter.

Below you can see Canaccord’s updated estimates for Dollarama.

Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Soma Gold: Q3 Earnings Impacted By Labour Strike

Thesis Gold: The Multi-Billion Dollar Lawyers-Ranch PFS

Why Canada Has So Few Projects That Can Be Built Before 2030 | Dan Wilton – First Mining

Recommended

Northern Superior Shareholders Set To Receive Shares Of ONGold Resources Friday

Goliath Resources Sees Rob McEwen Increase Ownership Interest

Related News

Shopify CEO Tobi Lütke Wants Financial Analysts To Be Held Accountable

Tobias Lütke, founder and CEO of Shopify, Inc. (TSX: SHOP), took to Twitter to ponder...

Tuesday, May 10, 2022, 04:28:00 PM

Haywood Initiates Coverage On Ascend Wellness With $16.50 Price Target

Haywood Capital Markets recently became the latest firm to initiate coverage on Ascend Wellness (CSE:...

Wednesday, September 1, 2021, 03:33:00 PM

Antibe: Canaccord Cuts Price Target From $5.00 To $1.20 After Drug Pivot

In early August, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Monday, October 18, 2021, 11:31:00 AM

Canaccord Reduces Centerra Gold’s Price Target To $21 Following Sale of Hardrock Project

On December 15th, Centerra Gold Inc (TSX: CG) agreed to sell its 50% stake in...

Wednesday, December 16, 2020, 11:59:00 AM

Curaleaf: Consensus Estimate Fourth Quarter Earnings Preview

Curaleaf Holdings (CSE: CURA) announced that they will be reporting their fourth quarter and year-end...

Tuesday, March 9, 2021, 12:26:00 PM